Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance
    • Letter to Our Stockholders

IGC Radica Patente para la Fórmula Hyalolex

April 10, 2018September 10, 2019 by charlie
Posted in News and Filings, Press Releases

Post navigation

← IGC Files Patent for Hyalolex Formulation
IGC Announces Financial Results for Fiscal Year Ended March 31, 2018 →

Site Map

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance
    • Letter to Our Stockholders

Contact

IGC
Potomac, MD, United States

info@igcinc.us
301-983-0998